PHARMACEUTICAL COMPOSITION CONTAINING ERIGERONTIS HERBA, GINSENG RADIX ET RHIZOMA, OPHIOPOGONIS RADIX AND SCHISANDRAE CHINENSIS FRUCTUS

摘要

The present invention belongs to the pharmaceutical field, and disclosed is a pharmaceutical composition containing Erigerontis herba, Ginseng radix et rhizoma, Ophiopogonis radix and a Schisandrae chinensis fructus extract. The pharmaceutical composition comprises common oral dosage forms such as capsules, tablets, oral liquids, dripping pills or granules. The preparation process provided by the present invention fully utilizes the caffeic acid ester ingredients in the Erigerontis herba and reduces the content of other harmful and invalid substances, improves the efficacy, and provides a more convenient, effective and high quality controlled modern traditional Chinese medicine for clinical application.